Tag: blair

William Blair downgrades Neumora Therapeutics, Inc. (NMRA) to a Hold

Neumora Therapeutics, Inc.: A Comprehensive Overview Introduction to Neumora Therapeutics, Inc. Neumora Therapeutics, Inc. (NASDAQ: NMRA) is a biotechnology company focused on developing innovative treatments for...

ARS Pharmaceuticals (SPRY) Receives a Buy from William Blair

ARS Pharmaceuticals (SPRY) Receives a Buy Rating: What Investors Should Know Introduction to the Report ARS Pharmaceuticals, known by its ticker symbol SPRY, has garnered attention...

William Blair Keeps Their Hold Rating on Lantheus (LNTH)

Lantheus Holdings, Inc. (LNTH) Analyst Rating Reiterated by William Blair In a recent update, William Blair analyst Andy Hsieh reaffirmed a "Hold" rating on shares...

Popular Articles